IRIS
SCUDERI, SIMONE LUCA ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.201
NA - Nord America 1.081
AS - Asia 648
SA - Sud America 105
Continente sconosciuto - Info sul continente non disponibili 77
AF - Africa 16
OC - Oceania 1
Totale 3.129
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 985
RU - Federazione Russa 685
CN - Cina 212
IT - Italia 205
SG - Singapore 193
BR - Brasile 76
HK - Hong Kong 74
VN - Vietnam 71
SE - Svezia 70
DE - Germania 59
CA - Canada 52
GB - Regno Unito 40
FR - Francia 36
BD - Bangladesh 29
FI - Finlandia 27
IN - India 24
NL - Olanda 18
MX - Messico 17
AR - Argentina 15
PL - Polonia 15
CR - Costa Rica 11
ES - Italia 10
BE - Belgio 8
AT - Austria 7
ZA - Sudafrica 7
JP - Giappone 6
TR - Turchia 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
EC - Ecuador 4
JM - Giamaica 4
NP - Nepal 4
CZ - Repubblica Ceca 3
GT - Guatemala 3
HN - Honduras 3
IE - Irlanda 3
IQ - Iraq 3
MA - Marocco 3
MY - Malesia 3
PH - Filippine 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
DZ - Algeria 2
LT - Lituania 2
NO - Norvegia 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
SV - El Salvador 2
AL - Albania 1
AU - Australia 1
CH - Svizzera 1
CY - Cipro 1
DM - Dominica 1
GE - Georgia 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.052
Salva come PNG Salva come JPEG
Città #
Ashburn 137
Singapore 124
Moscow 123
San Jose 91
Dallas 90
Milan 74
Hong Kong 72
New York 64
Beijing 40
Shanghai 39
Council Bluffs 37
Los Angeles 31
Santa Clara 27
Ho Chi Minh City 23
Munich 23
Phoenix 23
Hefei 20
Lauterbourg 18
Orem 15
Turku 15
Hanoi 14
North Bergen 14
Princeton 14
Chennai 13
Frankfurt am Main 13
Boardman 12
Lawrence 12
Warsaw 12
Buffalo 11
Chicago 11
Montreal 10
Rome 10
Amsterdam 9
Brooklyn 9
Helsinki 9
Miano 8
Nuremberg 8
São Paulo 8
Da Nang 7
Turin 7
Atlanta 6
London 6
Manchester 6
Mexico City 6
Naples 6
San José 6
Stockholm 6
Tokyo 6
Houston 5
Johannesburg 5
Barnet 4
Brussels 4
Cerano 4
Columbus 4
Denver 4
Guangzhou 4
Oudehaske 4
Pune 4
Querétaro 4
San Francisco 4
The Dalles 4
Valencia 4
Berlin 3
Jackson 3
Lappeenranta 3
Madrid 3
Monza 3
Mumbai 3
Omaha 3
Paderborn 3
Palermo 3
Poplar 3
Seattle 3
Tashkent 3
Thunder Bay 3
Toronto 3
Zhuhai 3
Acalanes Ridge 2
Baie-D'Urfé 2
Belfast 2
Belo Horizonte 2
Bergamo 2
Bethesda 2
Bexley 2
Birmingham 2
Brasília 2
Carapicuíba 2
Carney 2
Cesano Boscone 2
Chongqing 2
City of London 2
Columbia 2
Dhaka 2
Dublin 2
Florence 2
Genoa 2
Guarulhos 2
Guayaquil 2
Haiphong 2
Heredia 2
Totale 1.494
Salva come PNG Salva come JPEG
Nome #
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 178
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 177
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 164
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 145
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 138
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 138
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 136
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 134
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 134
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 127
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 124
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 116
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 116
ASSOCIATION BETWEEN BRCA 1/2 POLYMORPHISMS AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 116
Diagnostic and prognostic factors in patients with prostate cancer: A systematic review protocol 115
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 110
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 107
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 105
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 101
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 97
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial 97
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 96
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging 91
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history 85
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score 31
Surgical Management of PSMA PET-Positive Lymph Nodes in Prostate Cancer 27
Serenoa Repens–Lycopene–Selenium and Epilobium–Palmitoylethanolamide–Calendula after transperineal prostate biopsy: a tertiary single center experience 21
Patient selection for prostate cancer focal therapy guided by mpMRI–PSMA PET concordance and pathology review 21
Multicentre validation of the PRECISE scoring system for prostate MRI during active surveillance 19
PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study 17
Incidence and Predictors of Acute Kidney Injury and Acute Kidney Disease After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients 13
Re: ‘Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review’ 12
Not All Adverse Pathology Features Are Equal: Identifying Optimal Candidates for Adjuvant Radiotherapy among Patients with Adverse Pathology at Radical Prostatectomy 8
PD35-02 WHEN IS NEOADJUVANT ANDROGEN DEPRIVATION THERAPY BENEFICIAL FOR HIGHLY AGGRESSIVE PROSTATE CANCER CANDIDATES TO RADICAL PROSTATECTOMY? IMPLICATIONS FOR MULTI-MODAL TAILORED APPROACHES AND TRIALS DESIGN 7
PD35-01 WHICH PATIENTS WITH CN1 DISEASE AT PET/CT ARE AFFECTED BY SYSTEMIC DISEASE? IMPLICATIONS FOR TAILORED TREATMENT APPROACHES BASED ON A LARGE MULTI-INSTITUTIONAL SERIES 6
Totale 3.129
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.903
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202215 0 0 0 9 0 0 1 2 0 0 0 3
2022/2023110 30 23 9 8 3 12 3 15 0 0 2 5
2023/2024172 4 12 19 13 16 43 0 24 0 12 10 19
2024/2025390 31 13 11 8 19 41 65 65 35 20 32 50
2025/20261.876 112 101 85 208 149 51 140 177 581 138 74 60
2026/2027554 66 71 147 270 0 0 0 0 0 0 0 0
Totale 3.129